Stay updated on Dara-CyBorD in Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-CyBorD in Myeloma: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0 and now includes 26 locations, replacing the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T14:32:04.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:22:16.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:22:48.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content version.
    Difference
    0.1%
    Check dated 2024-06-27T10:12:58.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T08:58:57.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus Genetics related topics: Multiple myeloma, MedlinePlus related topics: Multiple Myeloma, Genetic and Rare Diseases Information Center resources: Multiple Myeloma, Drug Information available for: Dexamethasone, Cyclophosphamide, Bortezomib, Daratumumab, FDA Drug and Device Resources'. This change reflects additional information and resources related to multiple myeloma treatment and genetics.
    Difference
    94%
    Check dated 2024-06-25T08:29:02.000Z thumbnail image

Stay in the know with updates to Dara-CyBorD in Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.